Clinical and psychiatric comparison of diverticular disease of the colon and irritable bowel syndrome

Objective: to compare socio-demographic indicators, clinical symptoms, results of a psychiatrist consultation and psychometric testing, quality of life studies of patients with diverticular colon disease (DBTK) and irritable bowel syndrome (IBS).

Materials and methods: 112 patients with colon diverticulosis (DOC), clinically severe diverticulosis (CVD) and diverticular disease (DB) were examined, of which 26 were men, 86 were women, the average age was 64 ±10.7 years and 112 were patients with irritable syndrome intestines (IBS) (31 men, 81 women), average age — 37.2 ±12.6 years. Applied: irrigoscopy, colonoscopy, fecal fecal calprotectin analysis, in-person psychiatrist  consultation, SCL-90-K questionnaire and SF-36 questionnaire.

Results: Mental disorders, mainly of a nosogenic nature, were detected in 80 (71.4%) patients with DOC, CVD, and DB. A correlation was established between the severity of mental pathology and the stage of diverticulosis. With IBS, in 107 (95.5%) mental changes were determined mainly with depressive syndromes of various structures. Somatic manifestations did not show noticeable diff erences. The indices of FC were the same for IBS and PKD and exceeded for CVD and especially for DB.

Conclusion: Diff erences in DBTK and IBS were revealed in the fi eld of mental disorders of varying severity, which requires diff erentiated therapy. Clinical manifestations did not show signifi cant diff erences.

1. Levchenko SV, Lazebnik LB, Potapova VB, Rogozina VA. Clinical and Morphological Variants of Diverticular Disease in Colon. Eksp Klin Gastroenterol. 2013;(3):23–30.

2. Everhart JE, Ruhl CE. Burden of digestive diseases in the United States part II: lower gastrointestinal diseases. Gastroenterology. 2009;136:741–754. doi:10.1053/j.gastro.2009.01.015

3. Morini S, Ridola L, Hassan C, et al. Association between diverticulosis and colonic neoplastic lesions in individuals with a positive faecal immunochemical test. United European Gastroenterol J. 2017;5:134–138.

4. Peery AF, Martin CF, Levinson SE, Sandler RS. Colonic diverticula are not associated with an increased risk of colorectal adenomas. Am J Gastroenterol. 2015;110:1694–1697.

5. Štimac D, Nardone G, Mazzari A, et al. What’s New in Diagnosing Diverticular Disease. J Gastrointestin Liver Dis. 2019;28(suppl. 4):17–22. Published 2019 Dec 19. doi:10.15403/jgld-553

6. Rustom LBO, Sharara AI. The natural history of colonic diverticulosis: much ado about nothing? Infl amm Intest Dis. 2018;3:69–74.

7. Stollman N, Raskin J. B. Diverticular disease of the colon. Lancet. 2004;363:631–639.

8. Pautrat K, Bretagnol F, Huten N, de Calan L. Acute diverticulitis in very young patients: a frequent surgical management. Dis Colon Rectum. 2007;50:472–477.

9. Ambrosetti P. Value of CT for acute left-colonic diverticulitis: the surgeon’s view. Dig Dis. 2012;30:51–55.

10. Tursi A, Elisei W. Role of Inf lammation in the Pathogenesis of Diverticular Disease. Mediators Infl amm. 2019;2019:8328490. Published 2019 Mar 14. doi:10.1155/2019/8328490

11. Järbrink-Sehgal M. E., Andreasson A., Talley N. J., Agréus L., Song J. Y., Schmidt P. T. Symptomatic diverticulosis is characterized by loose stools. Clinical Gastroenterology and Hepatology. 2016;14(12):1763–1770. e1. doi: 10.1016/j.cgh.2016.06.014.

12. Kaiser AM, Jiang JK, Lake JP, et al. The management of complicated diverticulitis and the role of computed tomography. Am J Gastroenterol. 2005;100:910–917.

13. Tursi A, Brandimarte G, Elisei W, et al. Assessment and grading of mucosal inflammation in colonic diverticular disease. J Clin Gastroenterol. 2008;42:699–703.

14. Ivashkin V. T., Shelygin Y. A., Achkasov S. I., et al. Diagno stics and treatment of diverticular disease of the colon: guidelines of the Russian gastroenterological Association and Russian Association of Coloproctology. Russian Journal of Gastroenterology, Hepatology,

15. Coloproctology. 2016;26(1):65–80. (In Russ.) https://doi.org/10.22416/1382–4376–2016–26–1–65–80

16. Simren M, Palsson OS, Whitehead WE. Update on Rome IV Criteria for Colorectal Disorders: Implications for Clinical Practice. Curr Gastroenterol Rep. 2017;19(4):15. doi:10.1007/s11894–017–0554–0

17. Drossman D.A., Hasler W. L. Rome IV – Functional GI disorders: disorders of gut-brain interaction. Gastroenterology. 2016; 150(6): 1257–61.

18. Mumolo M. G., Bertani L., Ceccarelli L., et al. From bench to bedside: fecal calprotectin in inflammatory bowel diseases clinical setting. World Journal of Gastroenterology. 2018;24(33):3681–3694. doi: 10.3748/wjg.v24.i33.3681.

19. Tursi A, Brandimarte G, Elisei W, Giorgetti GM, Inchingolo CD, Aiello F. Faecal calprotectin in colonic diverticular disease: a case–control study. Int J Colorectal Dis. 2009;24:49–55. doi:10.1007/s00384–008–0595–9

20. Tursi A, Elisei W, Picchio M, Brandimarte G. Increased faecal calprotectin predicts recurrence of colonic diverticulitis. Int J Colorectal Dis. 2014;29:931–935. doi:10.1007/s00384–014–1884–0

21. Bolster LT., Papagrigoriadis S. Diverticular disease has an impact on quality of life – results of a preliminary study. Colorectal Dis. 2003; 5: 320–3.

22. Comparato G, Fanigliulo L, Aragona G. et al. Quality of life in uncomplicated symptomatic diverticular disease: is it another good reason for treatment? Dig Dis. 2007; 25: 252–9.

23. Humes DJ, Simpson J, Neal KR., et al. Psychological and colonic factors in painful diverticulosis. Br J Surg. 2008; 95: 195–8.